01Properties
- First veterinary drug approved for the indication of “suppression of deterioration of renal function”1.
- Evaluation by the veterinarian and owner has shown that RAPROS® improves QOL in cats with CKD, leading to high owner adherence to the treatment.
- Small tablet to reduce the burden of everyday treatment.
- RAPROS® improves anorexia in feline CKD. It also suppresses weight body loss and improve hypoactivity.
- High safety confirmed in clinical trial.
Chronic kidney disease requires lifelong management.
RAPROS®, a safe, effective and easy-to administer drug, is a novel solution to the treatment of feline CKD.
Note: 1. RAPROS® is currently approved for use in Japan and in Hong Kong.
